Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUCQ | ISIN: KYG0519B1023 | Ticker-Symbol: 36X
Stuttgart
03.04.25
08:07 Uhr
5,200 Euro
-0,150
-2,80 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
ASCENTAGE PHARMA GROUP INTERNATIONAL Chart 1 Jahr
5-Tage-Chart
ASCENTAGE PHARMA GROUP INTERNATIONAL 5-Tage-Chart
RealtimeGeldBriefZeit
5,1005,25023:00

Aktuelle News zur ASCENTAGE PHARMA GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoASCENTAGE-B (06855): VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES BY THE TRUSTEE FOR THE PURPOSE OF THE 2022 RSU SCHEME-
27.03.ASCENTAGE PHARMA GROUP INTERNATIONAL - 6-K, Report of foreign issuer1
27.03.Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan5
27.03.Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Should You Sell?2
ASCENTAGE PHARMA GROUP Aktie jetzt für 0€ handeln
27.03.Ascentage Pharma Group International GAAP EPS of -$0.18, revenue of $134.3M1
27.03.ASCENTAGE-B (06855): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 20241
27.03.JPMorgan sets Ascentage Pharma stock to Overweight, $27 target4
26.03.ASCENTAGE-B (06855): VOLUNTARY ANNOUNCEMENT - ASCENTAGE PHARMA TO PRESENT FIVE PRECLINICAL STUDIES FROM INNOVATIVE PIPELINE AT AMERICAN ASSOCIATION OF ...1
26.03.ASCENTAGE PHARMA GROUP INTERNATIONAL: Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 20252
13.03.ASCENTAGE-B (06855): NOTICE OF BOARD MEETING-
12.03.ASCENTAGE PHARMA GROUP INTERNATIONAL - 6-K, Report of foreign issuer1
12.03.ASCENTAGE PHARMA GROUP INTERNATIONAL: Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 20251
06.03.ASCENTAGE-B (06855): VOLUNTARY ANNOUNCEMENT - OLVEREMBATINIB GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE ...1
06.03.ASCENTAGE PHARMA GROUP INTERNATIONAL: Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)64ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing...
► Artikel lesen
25.02.ASCENTAGE PHARMA GROUP INTERNATIONAL - 6-K, Report of foreign issuer-
25.02.ASCENTAGE-B (06855): CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE-
13.02.ASCENTAGE-B (06855): CLOSING OF THE PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION IN RELATION TO THE OFFERING OF AMERICAN DEPOSITARY SHARES1
12.02.ASCENTAGE-B (06855): NEXT DAY DISCLOSURE RETURN1
11.02.ASCENTAGE PHARMA GROUP INTERNATIONAL - 6-K, Report of foreign issuer-
07.02.Ascentage Pharma announces underwriters partially exercise option to purchase additional ADS1
Seite:  Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1